Jan. 6, 2025 — Researchers have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer ... Scientists Develop Scans That Light-Up Aggressive ...

The DVC system was used to measure circadian activity changes indicative of lung cancer progression in KRAS and KRAS-LKB1 transgenic mouse models. Material and methods ... KRAS transgenic mice were a ...

25, 2024 — Researchers have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive ... A New Ventilator-on-a-Chip Model ...

Treatment for lung cancer varies according to age, type of cancer, extent of disease, tolerance to medication and patient preference. Treatment options include a combination of surgery, radiation, ...

Immunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer. Immunotherapy has been shown to improve survival in ...

It's long been thought that age is the most significant risk factor for cancer since, over time, genetic mutations accumulate in cells, and this gradual buildup can eventually lead to cancer ...

Like most cancer types, the chance of developing lung cancer increases with age. In the United States, lung cancer is most often diagnosed in people 65 or older. But lung cancer can occur at any age, ...

Our LUNG FORCE Heroes inspire, encourage and empower us to raise our voices for lung health. Read about their personal experiences with lung cancer, and become a LUNG FORCE Hero by sharing your story.

Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...

Research has found a link between getting too much or too little sleep and an increased risk of developing lung cancer. Having lung cancer may also affect your sleep. Getting enough high quality ...

The new Lung Ambition Alliance – launched in July last year – has identified three major challengers that are inhibiting long-term survival worldwide: late diagnosis, few treatment advances ...